Noxopharm

Noxopharm

Australian publicly-listed clinical stage drug development company discovering and developing novel treatments for cancer and inflammation.v.

HQ location
Sydney, Australia
Launch date
Employees
Market cap
$10.2m
Enterprise value
$8m
Share price
AUD0.05 NOX.AX
Company register number
Authorizing premium user...